Evidence map›Paper›PMID 19633780›Full record

ArticleDeutsches Arzteblatt international2008

Durability of bioprosthetic cardiac valves.

Grischa Hoffmann, Georg Lutter, Jochen Cremer

Open access · greenAbstract read
In one paragraph

Article in Deutsches Arzteblatt international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The Ross Procedure in Children with Congenital Heart Disease.Journal of cardiovascular development and disease · 2025
    Review
  4. Review
  5. Review
  6. Early Feasibility Study of a Hybrid Tissue-Engineered Mitral Valve in an Ovine Model.Journal of cardiovascular development and disease · 2024
    Article
  7. Review
  8. Article
  9. Patient Preferences for Long-Term Implant Care in Cochlear, Glaucoma and Cardiovascular Diseases.International journal of environmental research and public health · 2023
    Article
  10. Article
  11. Article
  12. The Ross procedure in children: a systematic review.Annals of cardiothoracic surgery · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Stented bioprostheses in aortic position.HSR proceedings in intensive care & cardiovascular anesthesia · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Grischa HoffmannKlinik für Herz- und Gefässchirurgie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 7, Kiel, Germany. grischa.hoffmann@gmx.de
Georg Lutter
Jochen Cremer
University of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe choice of type of heart valve prosthesis is determined by the patient's age since bioprostheses have a limited lifespan. This article reviews current recommendations and the literature on cardiac valve replacement.

methodsSelective literature search in Medline/PubMed back to 1996 and review of current national and international recommendations from specialist societies.

resultsThe recommendations guiding the type of heart valve replacement have been revised in recent years. Of particular interest are the new generation of biological prostheses with extended durability, a growing use of stentless bioprostheses, a decrease in mortality of reoperation and an increase in life expectancy. Comorbidities such as chronic renal insufficiency or chronic atrial fibrillation are no longer contraindications to bioprosthesis. The number of heart valve replacements in recent years rose despite a concomitant increase in valve repairs. Aortic valves are being increasingly replaced by bioprostheses. DISCUSSION: The choice of heart valve prosthesis should be tailored to each patient taking into account the patient's age, life expectancy, comorbidities, and life style. Different decisions may be made now than those based on earlier recommendations resulting in an individualized treatment, in patients over the age of 65 or 70.

Indexed as

biomaterialcardiac surgerycardiac valve replacementcomorbidityguidelineindication

Identifiers

PMID19633780
PMCPMC2696738
OpenAlexW2119212810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.